This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

EnteroMedics Inc (ETRM)

NASDAQ: Health Care

Company Cash Flow
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash Flow From Operating Activities
Net Income (Loss) -25.78M -23.46M -26.00M -17.35M
Operating Gains/Losses 0.00 767.00 1.27K 52.62K
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 26.63K -52.41K 0.00 10.01K
(Increase) Decrease in Inventories 143.27K -202.58K -1.07M 0.00
(Increase) Decrease In Other Current Assets 0.00 -813.06K 0.00 0.00
(Decrease) Increase In Payables 60.73K -224.56K 367.49K -109.95K
(Decrease) Increase In Other Current Liabilities 515.44K -2.62M 3.87M 583.64K
(Increase) Decrease In Other Working Capital 246.76K 0.00 -176.98K -60.35K
Other Non-Cash Items 5.96M 4.23M 2.89M 2.41M
Net Cash From Continuing Operations -18.43M -22.48M -19.94M -13.66M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -18.43M -22.48M -19.94M -13.66M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 1.00M 4.00M 0.00
Purchases of Property, Plant & Equipment -416.01K -76.39K -252.27K -2.59K
Acquisitions 0.00 0.00 0.00 0.00
Purchases of Short-Term Investments 0.00 0.00 -5.01M 0.00
Other Cash from Investing Activities 200.00K 0.00 6.33M -6.53M
Cash Provided by Financing Activities
Net Cash From Investing Activities -216.01K 923.61K 5.07M -6.53M
Issuance of Debt 0.00 5.35M 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 24.08M 11.20M 14.65M 6.46M
Repayment of Long-Term Debt -3.00M -752.84K -922.00K -1.89M
Repurchase of Capital Stock 0.00 -367.87K -1.21M -2.60M
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net -1.45M -50.00K 0.00 34.45M
Net Cash From Financing Activities 19.63M 15.38M 12.52M 36.42M
Effect of Exchange Rate Changes 0.00 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents 988.70K -6.18M -2.35M 16.22M
ETRM News

ETRM EnteroMedics Inc

Analysts Ratings for ETRM

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 4 4 4 4
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET ETRM ANALYST REPORT

Brokerage Partners

ETRM Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs